Reversible Dasatinib-Associated Pulmonary Hypertension Managed With Dual Therapy and Hemodynamic-Guided Withdrawal
Abstract
Background: Dasatinib is a recognized cause of drug-induced pulmonary arterial hypertension (PAH), which may occasionally present with severe hemodynamic compromise. Evidence regarding optimal management and safe withdrawal of targeted therapy after recovery remains limited.
Case summary: A 41-year-old woman with chronic myeloid leukemia treated with dasatinib presented with rapidly progressive dyspnea and right heart failure, requiring intensive care admission due to cardiac tamponade. Right heart catheterization confirmed high-risk precapillary PAH (mean pulmonary artery pressure: 40 mm Hg; pulmonary vascular resistance: 8 Wood units). Dasatinib was permanently discontinued, and initial dual oral PAH therapy with macitentan and tadalafil was started, leading to rapid clinical, functional, and echocardiographic improvement. Hemodynamic reassessment demonstrated complete normalization, allowing sequential withdrawal of pulmonary vasodilator therapy under close follow-up. The patient remained asymptomatic with a sustained low-risk profile after complete treatment discontinuation.
Discussion: This case highlights the potential reversibility of dasatinib-associated PAH and the role of invasive reassessment to guide safe therapy de-escalation.
Take-home message: Dasatinib-associated PAH can be fully reversible, and hemodynamic-guided withdrawal of therapy may be feasible in selected patients.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Protective effects of tadalafil and N-acetyl cysteine therapy on cisplatin-induced testicular toxicity
- The Use of Generative AI for Scientific Literature Searches for Systematic Reviews: ChatGPT and Microsoft Bing AI Performance Evaluation
- Sildenafil as a Candidate Drug for Alzheimer’s Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons
- Ozone-modified properties of pumpkin seed oil as anti-H. pylori, anticancer, anti-diabetic and anti-obesity agent
- Effectiveness of Low-Intensity Extracorporeal Shock Wave Therapy in Erectile Dysfunction: An Analysis of Sexual Function and Penile Hardness at Erection: An Umbrella Review
- Molecular Docking of Silymarin as a Ligand for Aromatase Enzyme and HIV-1 Reverse Transcriptase Using Molegro Virtual Docker
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.